Results 31 to 40 of about 1,349 (113)
X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the Bruton tyrosine kinase (Btk) gene. In order to identify the mutations in Btk gene in Iranian patients with antibody deficiency, 13 male patients with an XLA phenotype ...
"Asghar Aghamohammadi +11 more
doaj
Molecular studies on Burton's tyrosine kinase [PDF]
X-Linked agammaglobulinaemia (XLA) is a humoral immunodeficiency resulting from a block in the B cell maturation pathway at the pre-B cell stage. Affected males have normal numbers of pre-B cells in the bone marrow but virtually no mature B cells in the ...
Gaspar, Hubert Baburaj
core
P>We were interested in the question of whether the congenital lack of B cells actually had any influence on the development of the T cell compartment in patients with agammaglobulinaemia.
E Giorda +30 more
core +1 more source
Ibrutinib is highly effective in the treatment of chronic lymphocytic leukaemia (CLL), disrupting B cell receptor signalling through the inhibition of Bruton’s tyrosine kinase (Btk).
Naylor-Adamson, Leigh
core +1 more source
Molecular interactions of bruton's tyrosine kinase [PDF]
X-linked agammaglobulinaemia (XLA) is a primary immunodeficiency disorder characterised by a dramatic reduction in the numbers of peripheral B cells and immunoglobulins of all isotypes.
Cory, Giles Oliver Cholmondeley
core
A new case of autosomal recessive agammaglobulinaemia with impaired pre-B cell differentiation due to a large deletion of the IGH locus [PDF]
Males with X-linked agammaglobulinaemia (XLA) due to mutations in the Bruton tyrosine kinase gene constitute the major group of congenital hypogammaglobulinaemia with absence of peripheral B cells.
Milili, M +7 more
core
Constitutive protein-protien interactions regulate activity of Bruton´s-Tyrosine-Kinase in B-cells
Die Protein-Tyrosin-Kinase Btk ist ein entscheidendes Effektorprotein in der ITAM-abhängigen B-Zell-Antigen-Rezeptor (BZR)-Signalkaskade. Ihr Fehlen oder Dysfunktion führt beim Menschen zur X-gekoppelten Agammaglobulinämie (XLA).
Schulze, Wiebke
core +1 more source
Inhibidores de la tirosina quinasa de bruton: Nuevo enfoque en el tratamiento de la esclerosis múltiple [PDF]
La esclerosis múltiple es una enfermedad autoinmune que afecta al sistema nervioso central (SNC). Se diagnostica con mayor frecuencia entre los 20 y 40 años, afectando más a las mujeres que a los hombres y siendo una causa de discapacidad importante ...
Martínez Lobo, Javier
core
\ua9 2017 British Society for Immunology. Immunoglobulin replacement therapy enhances survival and reduces infection risk in patients with agammaglobulinaemia.
Alachkar H +12 more
core
Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Btk is a cytoplasmic protein tyrosine kinase (PTK) that has been directly implicated in the pathogenesis of X-linked agammaglobulinaemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice. We have isolated phage and cosmid clones that allowed us
Nilsson, L +11 more
core +1 more source

